Targeted therapy for vulvovaginal atrophy
O.P. Vinogradova +5 more
openaire +1 more source
Vulvovaginal atrophy (VVA) in breast cancer survivors (BCS) is still an unmet medical need: results of an Italian Delphi Panel. [PDF]
Biglia N +4 more
europepmc +1 more source
Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital® Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study. [PDF]
Fianu Jonasson A +4 more
europepmc +1 more source
Effects of topical estrogen therapy on the vaginal microcirculation in women with vulvovaginal atrophy. [PDF]
Diedrich CM +5 more
europepmc +1 more source
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women. [PDF]
Nappi RE +9 more
europepmc +1 more source
A systematic review of laser therapy for vulvovaginal atrophy/genitourinary syndrome of menopause in breast cancer survivors. [PDF]
Knight C, Logan V, Fenlon D.
europepmc +1 more source
Treatment to External Labia and Vaginal Canal With CO2 Laser for Symptoms of Vulvovaginal Atrophy in Postmenopausal Women. [PDF]
Samuels JB, Garcia MA.
europepmc +1 more source
Fractional CO2 laser treatment for vulvovaginal atrophy symptoms and vaginal rejuvenation in perimenopausal women. [PDF]
Arroyo C.
europepmc +1 more source
Vaginal dilator therapy for pelvic cancer patients: a review. [PDF]
Nair N +4 more
europepmc +1 more source
Navigating diagnostic uncertainty in vulvar lichen sclerosus: When clinical and histopathologic findings diverge. [PDF]
Kadam P, Pomeranz MK, Lipner SR.
europepmc +1 more source

